TDGF1 Antikörper (Internal Region)

Produktnummer ABIN401391

Produktdetails anti-TDGF1 Antikörper

Target: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Bindungsspezifität: Internal Region

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TDGF1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Spezifität: This antibody is specific for Cripto-1 protein. Expect cross-reactivity with Cripto-3 (TDGF2) based on very high levels of sequence conservation.

Kreuzreaktivität (Details): Species reactivity (expected):Mouse.
Species reactivity (tested):Human.

Aufreinigung: Affinity chromatography

Immunogen: Synthetic peptide corresponding to an internal sequence of human Cripto-1 protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA: 1/50,000 - 1/150,000. Western Blot: 1/500 - 1/2,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.80 mg/mL (by UV absorbance at 280 nm)

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 containing 0.01 % (w/v) Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Details zu TDGF1

Target: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Andere Bezeichnung: TDGF1 / CRIPTO (TDGF1 Produkte)

Synonyme: CR antikoerper, CRGF antikoerper, CRIPTO antikoerper, CR1 antikoerper, cripto antikoerper, cb85 antikoerper, tdgf1 antikoerper, wu:fe01d04 antikoerper, zgc:109829 antikoerper, Cripto-1 antikoerper, cr1 antikoerper, cr1a antikoerper, frl-1 antikoerper, frl1 antikoerper, xcr1 antikoerper, TDGF1 antikoerper, tdgf3 antikoerper, cripto-3 antikoerper, teratocarcinoma-derived growth factor 1 antikoerper, teratocarcinoma-derived growth factor 1, member 3 L homeolog antikoerper, teratocarcinoma-derived growth factor 1, member 1 antikoerper, TDGF1 antikoerper, Tdgf1 antikoerper, tdgf1 antikoerper, tdgf1.3.L antikoerper, tdgf1.1 antikoerper

Hintergrund: Human Cripto-1 (CR-1), also known as Teratocarcinoma-derived growth factor 1 (TDGF1), is a member of the epidermal growth factor (EGF)-GFC family and has been implicated in both embryogenesis and carcinogenesis. During early vertebrate development, CR-1 functions as a co-receptor for Nodal, a transforming growth factor beta (TGFbeta) family member, and is essential for mesoderm and endoderm formation and anterior-posterior and left-right axis establishment. In adult tissues, CR-1 is expressed at a low level in all stages of mammary gland development, and expression increases during pregnancy and lactation. Over-expression of CR-1 in mouse mammary epithelial cells leads to their transformation in vitro, and when injected in mammary glands, CR-1 produces ductal hyperplasias.Synonyms: CRGF, Cripto-1 growth factor, Epidermal growth factor-like cripto protein CR1, Teratocarcinoma-derived growth factor 1

Gen-ID: 6997

NCBI Accession: NP_001167607

UniProt: P13385

Pathways: EGFR Signaling Pathway